# Melatonin for Prevention of Post Stroke Delirium

> **NCT04122599** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 2000 (estimated)

## Conditions studied

- Post Stroke Delirium

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT04122599
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122599, "Melatonin for Prevention of Post Stroke Delirium". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04122599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*